Fetzima on Blue Medicare Rx Standard (S5540-002)
levomilnacipran hydrochloride
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$181.03
Patient pays / month, after deductible
$565.72
Patient pays / month, before the $615.00 deductible
$543.09
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
FETZIMA 80 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $565.72 for a month. Other covered strengths are listed below.
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| FETZIMA 120 mg Capsule, Extended Release | 4 | $181.33 | 30 per 30 days |
| FETZIMA 20 mg Capsule, Extended Release | 4 | $181.80 | 30 per 30 days |
| FETZIMA 40 mg Capsule, Extended Release | 4 | $181.14 | 30 per 30 days |
| FETZIMA 80 mg Capsule, Extended Release | 4 | $181.03 | 30 per 30 days |
| FETZIMA Kit | 4 | $184.69 | 28 per 28 days |
Verify with the plan before prescribing or filling. Member services: (888)247-4142. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5540-002